A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus

A Research Study of a New Medicine NNC0113-6856 in Healthy Males

NCT05521256 ·Status: COMPLETED ·Phase: PHASE1

Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes

NCT01774968 ·Status: COMPLETED ·Phase: PHASE4

Study of LX4211 in Subjects With Type 2 Diabetes Mellitus

NCT00962065 ·Status: COMPLETED ·Phase: PHASE2

A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients

NCT01253278 ·Status: COMPLETED ·Phase: PHASE1

Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus

NCT01236404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

NCT03117998 ·Status: COMPLETED ·Phase: PHASE2

A New Oral Treatment For Type II Diabetes Mellitus

NCT00111800 ·Status: COMPLETED ·Phase: PHASE2

A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes

NCT00400283 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

NCT06326047 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

NCT02305381 ·Status: COMPLETED ·Phase: PHASE3

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A

NCT01724814 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

NCT00790153 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

NCT03467932 ·Status: COMPLETED ·Phase: PHASE2

Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

NCT02715193 ·Status: COMPLETED ·Phase: PHASE1

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

NCT07112339 ·Status: RECRUITING ·Phase: PHASE4

Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus

NCT02346344 ·Status: COMPLETED

Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

NCT05272059 ·Status: WITHDRAWN ·Phase: PHASE1

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

NCT04596631 ·Status: COMPLETED ·Phase: PHASE3

Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes

NCT00411892 ·Status: TERMINATED ·Phase: PHASE3

Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes

NCT00511602 ·Status: COMPLETED ·Phase: PHASE2

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

NCT01177163 ·Status: COMPLETED ·Phase: PHASE1

First Time in Human Study Using GSK2330672

NCT01416324 ·Status: COMPLETED ·Phase: PHASE1

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.

NCT00424437 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy

NCT01353469 ·Status: COMPLETED ·Phase: PHASE3

A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

NCT03341013 ·Status: COMPLETED ·Phase: PHASE1